Strain Information | |
|---|---|
| Image | |
| BRC No. | RBRC02829 |
| Type | Transgene Congenic |
| Species | Mus musculus |
| Strain name | B6.B6C3-Tg(Th-SNCA*130m)1702Yosh |
| Former Common name | Syn130m-1702, B6.Cg-Tg(Th-SNCA*)1702Yosh |
| H-2 Haplotype | |
| ES Cell line | |
| Background strain | C57BL/6JJcl |
| Appearance | |
| Strain development | Developed by Masaki Wakamatsu, Makoto Yoshimoto, Taisho Pharmaceutical Co., Ltd. in 2001. The transgene was injected into the pronuclei of B6C3F1 fertilized eggs. The mutant mice were backcrossed C57BL/6. |
| Strain description | Th-SCNA transgenic mice expressing human alpha synuclein under the control of tyrosine hydroxylase promoter. Syn130m line (RBRC02829) having a human alpha synuclein sequence with an Ala53Thr point mutation and a lacking of 10 amino acids at the C-terminus, Syn140m line (RBRC02830) having a human alpa synuclein sequence with an Ala 53Thr point mutation. Syn130m line (RBRC02829) is useful as a model of Parkinson Disease. Syn130m Tg mice exhibit decreased dopamine level and dopaminergic neuron number. Motor activity and exploratory behavior are reduced compared to controls. Tg homozygous mice are postnatal lethal. Syn140m line (RBRC02830) is available as a control of Syn130m line. Syn140m Tg mice show no obvious abnormality. |
| Colony maintenance | Carrier x Noncarrier [C57BL/6JJcl] |
| References | Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease. Masaki Wakamatsu, Shingo Iwata, Takeo Funakoshi, Makoto Yoshimoto Neurosci. Res., 86. 640-646 (2008). 17896793Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice. Masaki Wakamatsu, Aiko Ishii, Shingo Iwata, Junko Sakagami, Yuriko Ukai, Mieko Ono, Daiji Kanbe, Shin-ichi Muramatsu, Kazuto Kobayashi, Takeshi Iwatsubo, Makoto Yoshimoto Neurobiol. Aging, 574-585 (2008). 17174013 |
Health Report | |
|---|---|
| Examination Date / Room / Rack | |
Gene | |||||||
|---|---|---|---|---|---|---|---|
| Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
| HBB2 | rabbit beta-globin intron | UN | HBB2 | ||||
| SNCA | synuclein, alpha (human) | UN | SNCA | rat tyrosine hydroxylase (TH) promoter | |||
| SV40 polyA additional signal | UN | ||||||
Phenotype | |
|---|---|
| Phenotype annotation from literatures by Mammalian phenotype ontology | more 2 phenotypes |
| Detailed phenotype data | |
Ordering Information | |
|---|---|
| Donor DNA | human mutated α-synuclein cDNA (A53T and a stop codon after amino acid 130), Rat Tyrosine hydroxylase promoter, Rabbit β-globin intron, SV40 polyA-additional signal |
| Research application | Mouse Models for Human Disease |
| Specific Term and Conditions | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Neurobiol. Aging, 29, 574-585 (2008). |
| Depositor | Taisho Pharmaceutical Co.,Ltd. (Taisho Pharmaceutical Co., Ltd.) |
| Strain Status | Frozen embryos Frozen sperm |
| Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
| Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
|---|
| No Data |